GFS Advisors, LLC

Position in LLY — ELI LILLY & Co

CIK 1427263 HOUSTON, TX

Position in LLY

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$359,829

-$26,474 QoQ

Shares Held

300

-28.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#4,022

of 4,605 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GFS Advisors, LLC holds $987,567 across 10 Drug Manufacturers - General names. LLY ranks #1 (36.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	300	$359,829
2	NVO	Novo Nordisk A S	5,840	$279,969
3	JNJ	Johnson & Johnson	46,182	$143,960
4	ABBV	AbbVie Inc.	10,263	$143,938
5	GSK	GSK plc	372	$19,500
6	BMY	Bristol Myers Squibb Co	26,710	$18,634
7	OGN	Organon & Co.	1,267	$17,155
8	MRK	Merck & Co., Inc.	79,011	$3,361

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$359,829	300	-28.6%	Shares	Sole	2026-08-04
2026-03-31	$386,303	420	+20.0%	Shares	Sole	2026-05-11
2025-12-31	$376,138	350	-41.7%	Shares	Sole	2026-02-11
2025-09-30	$457,800	600	-29.6%	Shares	Sole	2025-11-06
2025-06-30	$664,159	852	+32.1%	Shares	Sole	2025-07-25
2025-03-31	$532,711	645	0.0%	Shares	Sole	2025-04-21
2024-12-31	$497,940	645	-0.3%	Shares	Sole	2025-01-23
2024-09-30	$573,203	647	+158.8%	Shares	Sole	2024-10-29
2024-06-30	$226,345	250	-60.5%	Shares	Sole	2024-07-26
2024-03-31	$492,448	633	-44.1%	Shares	Sole	2024-04-25
2023-12-31	$660,448	1,133	-33.1%	Shares	Sole	2024-01-24
2023-09-30	$909,361	1,693	-5.4%	Shares	Sole	2023-10-19
2023-06-30	$839,005	1,789	-16.6%	Shares	Sole	2023-08-08
2023-03-31	$736,292	2,144	—	Shares	Sole	2023-04-27
No filing history on record for this holder in this stock.